Literature DB >> 9085061

Risk factors of surgical wound infection in patients undergoing herniorrhaphy.

M Medina1, M Sillero, G Martínez-Gallego, M Delgado-Rodríguez.   

Abstract

OBJECTIVE: To study the causes of surgical wound infection in patients being operated on for abdominal hernias.
DESIGN: Prospective cohort study.
SETTING: A tertiary hospital, Spain.
SUBJECTS: 497 subjects undergoing herniorrhaphy. MAIN OUTCOME MEASURES: Incidence of surgical wound infection during hospital stay and with an extended follow-up to one month after hospital discharge.
RESULTS: During follow-up, 40 patients (8%) developed wound infections. The risk was unrelated to ASA grade, sex, age, severity of underlying disease, or number of diagnoses. Logistic regression analysis included six variables in the model. The most important two were duration of intervention (OR for each hour = 2.1, 95% confidence interval (CI) = 1.1 to 4.0) and the infection risk of the surgeon (taking the medium-risk level as reference, OR for low risk = 0.16, 95% CI = 0.03 to 0.81; OR for high risk = 1.83, 95% CI = 0.84 to 3.96). Logistic regression also included cancer, morbid obesity, and serum creatinine and HDL-cholesterol concentrations in the final model. The deviance (as regarding a saturated model including the six variables) of a model including only duration of intervention and surgeon was lower than that of a model with the remaining four factors.
CONCLUSIONS: The risk of infection is governed mainly by factors associated with the operation.

Entities:  

Mesh:

Year:  1997        PMID: 9085061

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  17 in total

1.  Prosthetic repair of incisional hernia in kidney transplant patients. A technique with onlay polypropylene mesh.

Authors:  C Birolini; E Mazzucchi; E M Utiyama; W Nahas; A J Rodrigues; S Arap; D Birolini
Journal:  Hernia       Date:  2001-03       Impact factor: 4.739

2.  [Surgical standards in perioperative treatment].

Authors:  A Richter
Journal:  Chirurg       Date:  2012-04       Impact factor: 0.955

3.  Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy.

Authors:  M Hauer-Jensen; C Fort; J L Mehta; L M Fink
Journal:  Hernia       Date:  2005-09-08       Impact factor: 4.739

4.  The effect of tobacco consumption and body mass index on complications and hospital stay after inguinal hernia surgery.

Authors:  D Lindström; O Sadr Azodi; R Bellocco; A Wladis; S Linder; J Adami
Journal:  Hernia       Date:  2006-12-06       Impact factor: 4.739

5.  Surgical site infection - a European perspective of incidence and economic burden.

Authors:  David J Leaper; Harry van Goor; Jacqueline Reilly; Nicola Petrosillo; Heinrich K Geiss; Antonio J Torres; Anne Berger
Journal:  Int Wound J       Date:  2004-12       Impact factor: 3.315

6.  Risk factors for postoperative wound infections and prolonged hospitalization after ventral/incisional hernia repair.

Authors:  C Kaoutzanis; S W Leichtle; N J Mouawad; K B Welch; R M Lampman; W L Wahl; R K Cleary
Journal:  Hernia       Date:  2013-09-13       Impact factor: 4.739

7.  Does topical rifampicin reduce the risk of surgical field infection in hernia repair?

Authors:  Şahin Kahramanca; Oskay Kaya; Cem Azılı; Bahadır Celep; Emre Gökce; Tevfik Küçükpınar
Journal:  Ulus Cerrahi Derg       Date:  2013-06-01

8.  The effectiveness of i.v. cefuroxime prophylaxis of surgical site infection after elective inguinal hernia repair with mesh: A retrospective observational study.

Authors:  Yeye Zhuo; Qian Zhang; Danling Tang; De Cai
Journal:  Eur J Clin Pharmacol       Date:  2016-05-10       Impact factor: 2.953

9.  [Evidence-based antibiotic prophylaxis in general and visceral surgery].

Authors:  P Knebel; M A Weigand; M W Büchler; C M Seiler
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

10.  Open suture versus mesh repair of primary incisional hernias: a cost-utility analysis.

Authors:  K R Finan; M L Kilgore; M T Hawn
Journal:  Hernia       Date:  2009-01-14       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.